These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16961608)

  • 21. In vitro characterization of missense mutations associated with quantitative protein S deficiency.
    Okada H; Yamazaki T; Takagi A; Murate T; Yamamoto K; Takamatsu J; Matsushita T; Naoe T; Kunishima S; Hamaguchi M; Saito H; Kojima T
    J Thromb Haemost; 2006 Sep; 4(9):2003-9. PubMed ID: 16961607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis three abnormal Protein S genes in a patient with pulmonary embolism.
    Ikejiri M; Tsuji A; Wada H; Sakamoto Y; Nishioka J; Ota S; Yamada N; Matsumoto T; Nakatani K; Nobori T; Itoh M
    Thromb Res; 2010 Jun; 125(6):529-32. PubMed ID: 20181378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and phenotypic variability between families with hereditary protein S deficiency.
    Rezende SM; Lane DA; Zöller B; Mille-Baker B; Laffan M; Dahlbäck B; Simmonds RE
    Thromb Haemost; 2002 Feb; 87(2):258-65. PubMed ID: 11858485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activated protein C resistance, Leiden mutation, anticoagulant proteins and fibrinogen levels in patients with deep venous thrombosis].
    Jastrzebska M; Bałszan-Kowalska I; Ciechanowicz A; Bińczak-Kuleta A; Falkowski A; Chełstowski K
    Pol Arch Med Wewn; 2003 Jun; 109(6):579-88. PubMed ID: 14567090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk.
    Suchon P; Germain M; Delluc A; Smadja D; Jouven X; Gyorgy B; Saut N; Ibrahim M; Deleuze JF; Alessi MC; Morange PE; Trégouët DA
    Sci Rep; 2017 Apr; 7():45507. PubMed ID: 28374852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compound heterozygous mutations identified in severe type I protein S deficiency impaired the secretion of protein S.
    Zhou J; Shen W; Gu Y; Li M; Shen W
    J Clin Pathol; 2020 Jan; 73(1):7-13. PubMed ID: 31422373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two Novel Variants in the Protein S Gene PROS1 Are Associated with Protein S Deficiency and Thrombophilia.
    Juhl D; Kuta P; Shneyder M; Wünsche F; Nowak-Göttl U
    Acta Haematol; 2021; 144(2):222-226. PubMed ID: 32653888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Protein S deficiency in three patients with thrombosis].
    Minami R; Urata M; Kurihara M; Hara K; Abe Y; Muta K; Nawata H
    Rinsho Ketsueki; 2001 Aug; 42(8):610-5. PubMed ID: 11579499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein S gene mutation in a young woman with type III protein S deficiency and venous thrombosis during pregnancy.
    Hirose M; Kimura F; Wang HQ; Takebayashi K; Kobayashi M; Nakanishi K; Akiyama M; Kimura T; Noda Y
    J Thromb Thrombolysis; 2002 Apr; 13(2):85-8. PubMed ID: 12101385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cleaved protein S (PS), total PS, free PS, and activated protein C cofactor activity as risk factors for venous thromboembolism.
    Borgel D; Reny JL; Fischelis D; Gandrille S; Emmerich J; Fiessinger JN; Aiach M
    Clin Chem; 2003 Apr; 49(4):575-80. PubMed ID: 12651809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities.
    Koenen RR; Gomes L; Tans G; Rosing J; Hackeng TM
    Thromb Haemost; 2004 Jun; 91(6):1105-14. PubMed ID: 15175796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function.
    He X; Shen L; Villoutreix BO; Dahlbäck B
    J Biol Chem; 1998 Oct; 273(42):27449-58. PubMed ID: 9765274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of low-dose combined oral contraceptives and protein S K196E mutation on anticoagulation factors: a prospective observational study.
    Miyoshi T; Oku H; Asahara S; Okamoto A; Kokame K; Nakai M; Nishimura K; Otsuka F; Higashiyama A; Yoshimatsu J; Miyata T
    Int J Hematol; 2019 Jun; 109(6):641-649. PubMed ID: 30891674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera.
    Marchetti M; Castoldi E; Spronk HM; van Oerle R; Balducci D; Barbui T; Rosing J; Ten Cate H; Falanga A
    Blood; 2008 Nov; 112(10):4061-8. PubMed ID: 18768782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gamma-carboxyglutamic acid domain of anticoagulant protein S is involved in activated protein C cofactor activity, independently of phospholipid binding.
    Saller F; Villoutreix BO; Amelot A; Kaabache T; Le Bonniec BF; Aiach M; Gandrille S; Borgel D
    Blood; 2005 Jan; 105(1):122-30. PubMed ID: 15308562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutation.
    Koenen RR; Tans G; van Oerle R; Hamulyák K; Rosing J; Hackeng TM
    Blood; 2003 Sep; 102(5):1686-92. PubMed ID: 12730108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PROS1 variant c.1574C>T p.Ala525Val causes portal vein thrombosis with protein S deficiency.
    Ye X; Mi X; Sun J; ShenTu Y; Fei Y; Tang D; Ye X; Ma X; Shi J; Chen G; Gong L
    Clin Res Hepatol Gastroenterol; 2023 May; 47(6):102141. PubMed ID: 37207893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to activated protein C and low levels of protein S activity in nine thrombophilic families: a correct diagnosis.
    Gemmati D; Serino ML; Verzola I; Mari R; Moratelli S; Ballerini G
    Blood Coagul Fibrinolysis; 1997 Mar; 8(2):118-23. PubMed ID: 9518043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein S.
    Hepner M; Karlaftis V
    Methods Mol Biol; 2013; 992():373-81. PubMed ID: 23546730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function.
    Baroni M; Mazzola G; Kaabache T; Borgel D; Gandrille S; Vigano' D'Angelo S; Marchetti G; di Iasio MG; Pinotti M; D'Angelo A; Bernardi F
    J Thromb Haemost; 2006 Jan; 4(1):186-91. PubMed ID: 16409468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.